36C25225F0191↗
Novartis Pharmaceuticals Corporation received this contract from 252-Network Contract Office 12 (36C252), Department of Veterans Affairs: $1.73M obligated so far for drugs and biologicals. It runs to 2027-08-31.
Key facts · data as of Oct 25, 2026
- Recipient
- Novartis Pharmaceuticals Corporation
- Awarding agency
- Department of Veterans Affairs
- Contracting office
- 252-Network Contract Office 12 (36C252) (36C252)
- Obligated to date
- $1.73M
- Potential value
- $2.18M
- Ends
- 2027-08-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 36C25225F0191, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_36C25225F0191_3600_36F79720D0180_3600
Novartis Pharmaceuticals Corporation: all federal awards · Department of Veterans Affairs: spending · 252-Network Contract Office 12 (36C252): what it buys · The follow-on: recompete brief
DELIVERY ORDER FOR A BASE PLUS ONE (1) OPTION YEAR FOR THE RADIOPHARMACEUTICAL PLUVICTO.
Up for re-bid: ends 2027-08-31. Recompete brief →
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Pharmaceutical Preparation Manufacturing (NAICS 325412)
- Contracting office
- 252-Network Contract Office 12 (36C252) (36C252)
- Competition
- Full and open competition · 1 offer received
- Pricing
- Firm fixed price
- How it was bought
- GSA Schedule · under 36F79720D0180
- Where the work is
- Morris, NJ · district NJ-11
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
3 actions since 2025-08-27. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-08-24 | P00002 | Option exercised | $720.2K | DELIVERY ORDER FOR A BASE PLUS ONE (1) OPTION YEAR FOR THE RADIOPHARMACEUTICAL PLUVICTO. |
| 2026-01-28 | P00001 | Funding only | $514.4K | DELIVERY ORDER FOR A BASE PLUS ONE (1) OPTION YEAR FOR THE RADIOPHARMACEUTICAL PLUVICTO. |
| 2025-08-27 | 0 | $498.4K | DELIVERY ORDER FOR A BASE PLUS ONE (1) OPTION YEAR FOR THE RADIOPHARMACEUTICAL PLUVICTO. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗